Mouse Models for Immunotherapy in Hepatocellular Carcinoma
Enya Li1,2, Li Lin1, Chia-Wei Chen1
1Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Cancers
|November 17, 2019
Summary
Harnessing mouse models for liver cancer immunotherapy is vital. This review examines their utility, monitoring equipment, and cell strains for advancing hepatocellular carcinoma (HCC) treatment.
Area of Science:
- Oncology
- Immunology
- Translational Medicine
Background:
- Hepatocellular carcinoma (HCC) presents a significant global health challenge with low survival rates.
- Current immunotherapies for HCC show promise but limited response rates necessitate further research.
- Identifying novel immune targets and personalized treatment strategies are critical for improving HCC outcomes.
Purpose of the Study:
- To review the advantages and disadvantages of using mouse models in cancer immunotherapy research.
- To discuss essential equipment for monitoring hepatocellular carcinoma (HCC) progression in preclinical studies.
- To outline common cell strains employed for inducing HCC in experimental models.
Main Methods:
- Literature review of studies utilizing mouse models for HCC immunotherapy.
- Analysis of equipment and technologies for monitoring tumor growth and immune response.
- Compilation of data on cell strains used for HCC induction in mice.
Main Results:
- Mouse models offer cost-effectiveness and high tumor induction success for immunotherapy research.
- Immune-competent mouse models are crucial for elucidating the immune system's role in HCC.
- Specific equipment and cell strains are essential for robust and reproducible HCC research in mice.
Conclusions:
- Mouse models are indispensable tools for advancing HCC immunotherapy research.
- Standardized monitoring equipment and well-characterized cell strains enhance the reliability of preclinical HCC studies.
- Further research using optimized mouse models is crucial for developing effective combination therapies for HCC.
